Program Schedule
  For session summaries click on the session titles
 
Friday, May 17 2002
 
  3:00 -- 7:00 pm Arrival and Registration
  7:30 -- 10:00 pm Welcoming Reception (private invitation only)
Saturday, May 18th 2002
  7:00 -- 8:30 am Registration and Breakfast
  8:30 -- 8:45 am Giovanna Spinella, MD --
Welcome and Opening Remarks
  8:45 -- 10:20 am Session I – Neurochemistry Associated with Pediatric Neurotransmitter Diseases Darryl C. De Vivo, MD -- Chair
  8:45 -- 9:10 am O.C. Snead, MD -- “Functional Aspects of GABA Neurotransmission”
  9:10 -- 9:40 am Teodoro Bottiglieri, PhD -- “Biogenic Amines-Metabolism and Regulation”
  9:40 -- 10:05 am O. C. Snead, MD -- “GHB: A Potential Neurotransmitter in Mammalian CNS”
  10:05 -- 10:20 am Roundtable Discussion
  10:20 -- 10:35 am Break
  10:35 -- 12:30 pm Session II – Clinical Overview of PNDs
Andrea Gropman, MD -- Chair
  10:35 -- 11:00 am Kathryn Swoboda, MD -- “Aromatic L-Amino Acid Decarboxylase Deficiency”
  11:00 -- 11:25 am George F. Hoffmann, MD -- “Tyrosine Hydroxylase Deficiency”
  11:25 -- 11:50 pm Darryl C. De Vivo, MD -- “Segawa Disease (Dominantly Inherited GTP Cyclohydrolase Deficiency)
  11:50 -- 12:15 pm Phillip Pearl, MD -- “Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency (4-Hydroxybutyric Aciduria) in Children and Adults”
  12:15 -- 12:30 pm Roundtable Discussion
  12:30 -- 1:30 pm Lunch
  1:30 -- 4:10 pm Session III -- Diagnoses and Therapeutic Intervention for PNDs
Keith Hyland, PhD -- Chair
  1:30 -- 2:00 pm George F. Hoffmann, MD -- “The Clinician’s Approach to the Diagnosis of the Patient with a Suspected PND”
  2:00 -- 2:30 pm Keith Hyland, PhD -- “The Lumbar Puncture for Diagnosis of PNDs”
  2:30 -- 2:45 pm Roundtable Discussion
  2:45 -- 3:00 pm Coffee Break
  3:00 -- 3:30 pm Blair Ford, MD -- “Therapeutic Intervention for Disorders of Biogenic Amine Metabolism”
  3:30 -- 3:55 pm Andrea Gropman, MD -- “Vigabatrin and Newer Interventions in SSADH Deficiency”
  3:55 -- 4:10 pm Roundtable Discussion
  4:10 -- 5:00 pm Summary Discussion -- “Strategy Planning for Implementation of Goals and Objectives of the PND Association”-Chaired by the Scientific Organization Committee and Invited Speakers (open to all participants)
 

5:00 pm

Adjourn
  7:30 pm Conference Dinner (private invitation only)
  Sunday, May 19, 2002  
  7:00 -- 8:00 am Breakfast
  8:15 -- 9:50 am Session IV – Animal Models of PNDs Kathryn Swoboda, MD -- Chair
  8:15 -- 8:40 am Marc Caron, MD -- “Animal Models of Catecholamine Defects”
  8:40 -- 9:10 am K. Michael Gibson, PhD -- “New Therapeutic Insights from a Murine Model of SSADH Deficiency”
  9:10 -- 9:35 am Keith Hyland, PhD -- “The hph-1 Mouse, a Model of GTP Cyclohydrolase Deficiency”
  9:35 -- 9:50 am Roundtable Discussion
  9:50 -- 10:05 am Break
  10:05 -- 11:15 am Session V -- Future Directions for Research And Treatment of PNDs
G. Hoffmann, MD -- Chair
  10:05 -- 10:35 am Markus Grompe, MD -- “The Potential Role of Hepatocyte Repopulation in Treating PNDs”
  10:35 -- 11:05 am Clive Svendsen, PhD – “Genetic Modification of Human Neuronal Stem Cells; Implications for Brain Repair”
  11:05 -- 11:15 am Roundtable Discussion
  11:15 -- 12:10 pm Summary Discussion -- “What are the Future Objectives of the PND Association, and How Do We Coordinate to Achieve Our Goals”-Chaired by the Scientific Organizing Committee and Invited Speakers (open to all participants)
 

12:10 -- 12:25 pm

Giovanna Spinella, MD and Darryl C. De Vivo, MD --Concluding Remarks and Closing

 

12:30 pm

Adjourn
© 2003 Pediatric Neurotransmitter Disease Association
www.pndassoc.org